Publications by authors named "Fred Bosman"

Claim this Profile
A
A quantitative tumor-wide analysis of morphological heterogeneity of colorectal adenocarcinoma.
Mihnea P Dragomir, Vlad Popovici, Simon Schallenberg, Martina Čarnogurská, David Horst, Fred Bosman

J Pathol Clin Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Explorative Analysis of mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial.
Jan Stenvang, Eva Budinská, Eric van Cutsem, Fred Bosman, Vlad Popovici

Cancers (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trial.
Sabine Tejpar, Pu Yan, Hubert Piessevaux, Daniel Dietrich, Peter Brauchli, Fred Bosman

Eur J Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
Alessandro Lugli, Richard Kirsch, Yoichi Ajioka, Fred Bosman, Gieri Cathomas

Mod Pathol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparing pathology for the molecular era.
Fred T Bosman, George J Netto

Virchows Arch· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data.
Ida Kappel Buhl, Sarah Gerster, Mauro Delorenzi, Thomas Jensen, Peter Buhl Jensen, Fred Bosman

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Image-based surrogate biomarkers for molecular subtypes of colorectal cancer.
Vlad Popovici, Eva Budinská, Ladislav Dušek, Michal Kozubek, Fred Bosman

Bioinformatics· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The TNM classification of malignant tumours-towards common understanding and reasonable expectations.
Brian O'Sullivan, James Brierley, David Byrd, Fred Bosman, Sean Kehoe

Lancet Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Four-Gene Promoter Methylation Marker Panel Consisting of and Predicts Survival of Clear Cell Renal Cell Cancer Patients.
Iris J H van Vlodrop, Sophie C Joosten, Tim De Meyer, Kim M Smits, Leander Van Neste, Fred T Bosman

Clin Cancer Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression.
David Barras, Edoardo Missiaglia, Pratyaksha Wirapati, Oliver M Sieber, Robert N Jorissen, Fred T Bosman

Clin Cancer Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA Topoisomerase I Gene Copy Number and mRNA Expression Assessed as Predictive Biomarkers for Adjuvant Irinotecan in Stage II/III Colon Cancer.
Sune Boris Nygård, Ben Vainer, Signe Lykke Nielsen, Fred Bosman, Sabine Tejpar

Clin Cancer Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Communication skills in diagnostic pathology.
Hans-Anton Lehr, Fred T Bosman

Virchows Arch· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality in pathology: how good is good? An introduction.
Fred T Bosman, Hans-Anton Lehr

Virchows Arch· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.
Niels F Jensen, Jan Stenvang, Mette K Beck, Barbora Hanáková, Kirstine C Belling, Fred Bosman

Mol Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response.
Mauro Delorenzi, Sabine Tejpar, Arnaud D Roth, Fred T Bosman,

J Natl Cancer Inst· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The good, the bad, and the ugly.
Fred T Bosman

Virchows Arch· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Molecular pathology of colon cancer].
Fred T Bosman, Pu Yan

Pol J Pathol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
Antonio F Di Narzo, Sabine Tejpar, Simona Rossi, Pu Yan, Vlad Popovici, Fred T Bosman

J Natl Cancer Inst· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic biomarkers: an introduction.
Fred T Bosman, Lawrence D True

Virchows Arch· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Step by step.
Fred Bosman

Virchows Arch· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large proximal serrated polyps: natural history and colorectal cancer risk in a retrospective series.
Mariëlle W E Bouwens, Robert G Riedl, Fred T Bosman, Ann Driessen, Silvia Sanduleanu

J Clin Gastroenterol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer.
Eva Budinska, Vlad Popovici, Sabine Tejpar, Giovanni D'Ario, Nicolas Lapique, Fred Bosman

J Pathol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer.
Vlad Popovici, Eva Budinska, Fred T Bosman, Sabine Tejpar, Arnaud D Roth

BMC Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How far did we get?
Fred T Bosman

Virchows Arch· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer.
Arnaud D Roth, Mauro Delorenzi, Sabine Tejpar, Pu Yan, Dirk Klingbiel, Fred Bosman

J Natl Cancer Inst· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis